Preparation method of wound hemostasis and wound healing agent and wound hemostasis and wound healing agent
By using a dual syringe in the wound hemostasis guaiacin agent to mix bisaldehyde group-containing oxidative polysaccharides and water-soluble chitosan, and adding plasma discharge and cosolvents to form a gel-like guaiacin agent that quickly forms. The long dissolution time and insufficient storage stability of existing hemostatic materials have achieved efficient wound closure and hemostatic effects, and reduced the risk of damage to the organs by pancreatic juice.
Patent Information
- Application Number
- CN202411085514.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-08
- Publication Date
- 2024-11-19
AI Technical Summary
Existing wound hemostasis materials such as gelatin sponge, collagen sponge and fibrin gel have poor hydrophilicity, insufficient storage stability, long dissolution time, and risks of antigenicity and virus transmission, which affects their application effect in clinical practice.
Using a preparation method of wound hemostasis guaiac agent, by dissolving the oxidative polysaccharide containing bisaldehyde group and water-soluble chitosan respectively and mixing it in a dual syringe, the plasma discharge treatment and the aid solvent are accelerated to form rapid formation. The gel-like guaiacin of the gel improves its adhesion and hemostatic effect, and enhances its dissolution rate and anti-pancreatic degradation ability through improved agents such as borate bioactive glass and graphene oxide.
Shorten the dissolution time of hemostatic guaifetal agent, improve the glue-forming speed and hemostatic effect, enhance the wound sealing ability, reduce the risk of damage to the organs by pancreatic juice, and is not easily degraded by pancreatic juice, significantly improve the convenience and safety of clinical use sex.
Smart Images

Figure BDA0004985077210000101 
Figure BDA0004985077210000111
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of medical supplies, and more specifically, to a method for preparing a wound hemostatic and wound healing agent and the wound hemostatic and wound healing agent. Background Art
[0002] Controlling bleeding, stopping bleeding, and promoting wound healing during and after clinical surgery are very important for shortening the operation time, improving the surgical effect, and reducing postoperative complications. Conventional hemostatic methods such as ligation, suturing, and electrocoagulation are often used for hemostasis of clinical surgical operations and trauma hemostasis, but these hemostatic methods are not always able to effectively control bleeding. Therefore, according to clinical needs, a variety of local hemostatic materials have been used, and these hemostatic materials mainly include gelatin sponges, collagen sponges, fibrin glue and other products. Gelatin sponges have been used clinically for many years, but their hydrophilicity is poor, and their hemostatic effect is poor for larger bleeding. The hemostatic performance of collagen sponges is better than that of gelatin sponges, and its production raw materials come from bovine Achilles tendons and tendons, so there is also a risk of viral disease transmission. Fibrin glue is widely used in clinical surgical hemostasis, but because the fibrin glue component belongs to a blood product, there is a certain antigenicity and a risk of viral disease transmission, and its application safety is questioned to a certain extent. The above-mentioned gelatin sponges, collagen sponges, and fibrin glues are all xenobiotic animal proteins, and all have certain immunogenicity and the risk of viral transmission.
[0003] In the prior art, the Chinese invention patent document with application number CN101209354 discloses a medical wound hemostatic healing agent, which is composed of two parts of aqueous solution, one part is an oxidized polysaccharide aqueous solution containing a dialdehyde group, and the other part is a water-soluble chitosan aqueous solution. However, this wound healing agent is not resistant to high temperatures because the polysaccharide aqueous solution has a short shelf life at room temperature, and needs to be stored under a low temperature environment. When it is prepared by the factory and transported to the hospital for use, a refrigerated environment is required during transportation, and the transportation and storage conditions are strictly required. In order to improve the storage stability of the hemostatic material, the prior art also discloses that the water-soluble wound healing agent is changed to a powder-type wound healing agent, which is used and prepared before clinical surgery, but the powder-type hemostatic material has a long dissolution time when it is clinically prepared, which is inconvenient for clinical use, and the gelling speed of the two powders after they are dissolved and mixed into gel needs to be improved. Summary of the invention
[0004] In order to shorten the dissolution time of a powder-type hemostatic material and quickly form gel, the present application provides a method for preparing a wound hemostatic and wound healing agent and a wound hemostatic and wound healing agent.
[0005] In a first aspect, the present application provides a method for preparing a wound hemostatic and wound healing agent, using the following technical solution: A method for preparing a wound hemostatic and wound healing agent comprises the following steps: Preparation of materials before surgery: weigh the required oxidized polysaccharide containing dialdehyde groups and water-soluble chitosan and set aside; Dissolving the oxidized polysaccharide containing dialdehyde groups: mixing the oxidized polysaccharide containing dialdehyde groups with a solvent, heating to 37-40° C., and then stirring until completely dissolved to obtain an aqueous solution of the oxidized polysaccharide containing dialdehyde groups with a mass percentage concentration of 0.5-5%; Dissolving water-soluble chitosan: mixing water-soluble chitosan with a solvent, heating to 37-50°C, treating with plasma discharge at a power of 65-70W for 1.5-2min, stirring at a speed of 150-200r / min until completely dissolved, to obtain a water-soluble chitosan aqueous solution; mixing to form a gel: taking a dialdehyde-containing oxidized polysaccharide aqueous solution and a water-soluble chitosan aqueous solution at a mass ratio of 0.7-1.5:1, adding them into a double syringe respectively, and injecting them to form a gel-like wound hemostatic and healing agent; The oxidized polysaccharide containing dialdehyde groups is selected from one of oxidized hydroxyethyl cellulose containing dialdehyde groups, oxidized hydroxypropyl cellulose containing dialdehyde groups, oxidized carboxymethyl cellulose sodium salt or potassium salt containing dialdehyde groups, oxidized chitosan containing dialdehyde groups, oxidized hydroxyethyl chitosan containing dialdehyde groups, oxidized hydroxypropyl chitosan containing dialdehyde groups, oxidized carboxymethyl chitosan sodium salt or potassium salt containing dialdehyde groups, oxidized hydroxyethyl chitin containing dialdehyde groups, oxidized hydroxypropyl chitosan containing dialdehyde groups, oxidized carboxymethyl chitosan sodium salt or potassium salt containing dialdehyde groups, oxidized hyaluronic acid sodium salt or potassium salt containing dialdehyde groups, and oxidized alginate sodium salt or potassium salt containing dialdehyde groups; the water-soluble chitosan is selected from one of carboxymethyl chitosan sodium salt or potassium salt, hydroxyethyl chitosan, and hydroxypropyl chitosan.
[0006] By adopting the above technical scheme, during clinical surgery, the oxidized polysaccharide containing dialdehyde groups and the water-soluble chitosan are dissolved separately, and then added into a double syringe, injected, and mixed into a gel. Under a certain temperature and plasma treatment, the hydrophilicity of the water-soluble chitosan is increased, the solubility is increased, and the water-soluble chitosan can be quickly dissolved to obtain a completely dissolved aqueous solution of the oxidized polysaccharide containing dialdehyde groups. The water-soluble chitosan is dissolved at a certain stirring speed and temperature to accelerate its dissolution speed, shorten the dissolution time, and reduce the time required for preparation on the spot, so as to facilitate clinical use. Then, when mixing into a gel, a stirring agent is used to stir the water-soluble chitosan. The aqueous solution of oxidized polysaccharide containing dialdehyde group and the aqueous solution of water-soluble chitosan are pushed out from the double syringe at a constant speed, and the dialdehyde group in the oxidized polysaccharide containing dialdehyde group reacts with the amino group in the water-soluble chitosan by chemical covalent bonding, thereby forming a colloid. The gel formed by the two has a strong adhesion to the wound surface, thereby improving the hemostatic and sealing performance. At the same time, due to the good biocompatibility of the oxidized polysaccharide containing dialdehyde group and the water-soluble chitosan, they will not cause tissue immune response, and will not react to the body after being degraded in the body. In addition, during pancreatic surgery, the wound surface is blocked to prevent pancreatic juice leakage and avoid digestive fluid from damaging organs.
[0007] Optionally, the mass ratio of the aqueous solution of the dialdehyde-containing oxidized polysaccharide to the aqueous solution of the water-soluble chitosan is 0.78:1.
[0008] By adopting the above technical scheme, when the aqueous solution of oxidized polysaccharide containing dialdehyde group and the aqueous solution of water-soluble chitosan in the above mass ratio are mixed to form gel, the gelling speed is fast, the adhesion to the wound surface is strong, and the hemostatic and sealing effect is good.
[0009] Optionally, when the water-soluble chitosan is dissolved, before the plasma discharge treatment, a co-solvent is added, and the mass ratio of the water-soluble chitosan to the co-solvent is 1:0.1-0.3.
[0010] By adopting the above technical solution, the cosolvent is added when the water-soluble chitosan is dissolved and mixed with the solvent, which can increase the dissolution rate of the water-soluble chitosan and shorten the dissolution time, which is more conducive to clinical use.
[0011] Optionally, the co-solvent comprises polyethylene glycol-poly-L-lysine, sodium carbonate and polyoxyethylene fatty acid ester in a mass ratio of 1:0.5-1:1-2.
[0012] By adopting the above technical scheme, polyethylene glycol-poly L-lysine can form hydrogen bonds with water to increase the solubility of water-soluble chitosan, while sodium carbonate can accelerate the dispersion speed of water-soluble chitosan in the solvent and increase its solubility in the solvent. Polyoxyethylene fatty acid ester as a surfactant can increase the process of water-soluble chitosan dissolving to form a solution. The three work together to shorten the dissolution time, shorten the preparation time and make it more convenient. In addition, polyethylene glycol-poly L-lysine and sodium carbonate can be used as cross-linking agents when the oxidized polysaccharide containing dialdehyde groups and water-soluble chitosan undergo Schiff base reaction, thereby increasing the gelation speed and shortening the gelation time.
[0013] Optionally, when the water-soluble chitosan is dissolved, an improver is added, and the improver includes borate bioactive glass, graphene oxide and propylene glycol in a mass ratio of 1:2-3:0.2-0.3.
[0014] By adopting the above technical solution, borate bioactive glass will release a large amount of alkaline ions, change the surrounding acid-base environment, make the water-soluble chitosan solution acidic, and accelerate the dissolution of chitosan. In addition, borate bioactive glass uses boron as the glass network matrix and can realize specific physiological functions. It has good dopability and degradability. The mechanism by which it exerts its physiological function is that elements such as boron and calcium in its components will be released into body fluids after metabolism. These elements can stimulate angiogenesis and promote wound healing. Propylene glycol further improves the dispersibility of water-soluble chitosan and can also increase the water-soluble graphene oxide. The dispersion degree of chitosan in the solution can prevent it from agglomerating. Graphene oxide contains epoxy and hydroxyl groups. When water-soluble chitosan reacts with oxidized polysaccharides containing dialdehyde groups in a Schiff base reaction, it is used as a cross-linking agent to improve the space in which the chain segments in the network structure of the gel can move freely, resist the increase of external forces, and improve the mechanical properties of the gel. Moreover, the CN bond formed by the reaction of epoxy groups and amino groups is not easy to break under acidic conditions, making the gel material not easy to be degraded in pancreatic juice, thereby enhancing the sealing ability of pancreatic surgical wounds. In addition, graphene oxide has a good inhibitory effect on different types of bacteria and viruses, and can avoid wound infection.
[0015] Optionally, the mass ratio of the water-soluble chitosan to the improver is 1:0.1-0.3.
[0016] By adopting the above technical scheme, the improver with the above mass ratio can increase the dissolution rate of water-soluble chitosan, shorten the dissolution time, be more conducive to immediate preparation, increase the gelation rate, shorten the gelation time, and improve the adhesion of the gel and the ability to prevent pancreatic juice degradation.
[0017] Optionally, the water-soluble chitosan is a water-soluble chitosan with a molecular weight of 50KDa-100KDa.
[0018] By adopting the above technical solution, water-soluble chitosan with the above molecular weight can increase the permeability of the solvent, thereby increasing the solubility of the water-soluble chitosan and reducing the dissolution time.
[0019] Optionally, metal ions are added before the aldehyde-containing oxidized polysaccharide is dissolved, the metal ions are selected from at least one of calcium chloride, zinc chloride, copper sulfate and ferric chloride, and the mass ratio of the aldehyde-containing oxidized polysaccharide to the metal ions is 1:0.005-0.03.
[0020] By adopting the above technical scheme, when using water-soluble chitosan with a molecular weight of 50-100KDa, adding metal ions to the aldehyde-containing oxidized polysaccharide, and using calcium chloride as a cross-linking agent, the gelling property and hemostatic effect of the wound healing agent can be improved, and using zinc chloride, ferric chloride and copper sulfate as cross-linking agents can increase the gelling speed of the product.
[0021] Optionally, the water-soluble chitosan and the oxidized polysaccharide containing aldehyde groups are pretreated as follows: The water-soluble chitosan and the oxidized polysaccharide containing dialdehyde groups are added to the solvent respectively, and nitrogen or supercritical carbon dioxide is continuously filled for 10-20 minutes before freeze drying.
[0022] By adopting the above technical scheme, water-soluble chitosan and aldehyde-containing oxidized polysaccharide are dissolved separately, nitrogen or supercritical carbon dioxide is introduced, and then they are quickly freeze-dried, so that both form a sponge-like structure, thereby increasing the contact area and improving the dissolution rate when mixed with the solvent.
[0023] Optionally, before mixing and dissolving the water-soluble chitosan or aldehyde-containing oxidized polysaccharide with the solvent, the outer wall of the glass container storing the water-soluble chitosan or aldehyde-containing oxidized polysaccharide is repeatedly rubbed with a brush for 5-10 minutes to generate static electricity on the outer wall of the glass container, and then the solvent is injected.
[0024] By adopting the above technical solution, after repeated friction between the brush and the outer wall of the storage glass container, static electricity is generated on the outer wall of the storage glass container. The outer wall of the glass container is negatively charged, while the brush is positively charged. The static electricity generated by the outer wall causes the water-soluble chitosan or aldehyde-containing oxidized polysaccharide in the storage glass container to be adsorbed on the inner wall of the storage glass container, thereby achieving a dispersion effect. When the solvent is injected, the dissolution rate is increased and the dissolution time is reduced.
[0025] Optionally, the solvents of the aqueous solution of oxidized polysaccharide containing dialdehyde groups and the aqueous solution of water-soluble chitosan are both selected from the group consisting of distilled water, water for injection, physiological saline and Ringer's solution.
[0026] In a second aspect, the present application provides a wound hemostatic and wound healing agent, which adopts the following technical solution: A wound hemostasis and wound healing agent is prepared by the preparation method of the wound hemostasis and wound healing agent.
[0027] By adopting the above technical scheme, the wound hemostatic and wound healing agent prepared by the above preparation method has high adhesion to the wound, good blocking and hemostatic effect, and is not easily degraded by pancreatic juice, and can prevent tissue fluid from damaging organs; and compared with fibrin glue, it has more superior and significant wound sealing effect, hemostatic effect, wound healing promotion effect and tissue adhesion prevention effect.
[0028] In summary, this application has the following beneficial effects: 1. The method of the present application treats the water-soluble chitosan with plasma and stirs the dialdehyde-containing oxidized polysaccharide at a certain temperature and rotation speed, thereby accelerating the dissolution rate of the dialdehyde-containing oxidized polysaccharide and the water-soluble chitosan. When the hemostatic and wound-healing agent is prepared before clinical surgery, the preparation time is short, the operation is convenient, and the gelling speed is fast. The prepared wound-healing agent has excellent wound sealing effect, hemostatic effect, wound healing promotion effect and tissue adhesion prevention effect, is not easily decomposed by pancreatic juice, and reduces the damage of pancreatic juice to organs.
[0029] 2. In the present application, it is preferred to add a cosolvent when the water-soluble chitosan is dissolved, and the cosolvent is polyethylene glycol-poly L-lysine, sodium carbonate and polyoxyethylene fatty acid ester. The cosolvent can not only accelerate the dissolution rate of the water-soluble chitosan, but also increase the Schiff base reaction rate of the oxidized polysaccharide containing dialdehyde group and the water-soluble chitosan, shorten the gelation time, and accelerate the hemostasis speed.
[0030] 3. In the present application, it is preferred to add a modifier when the water-soluble chitosan is dissolved. The modifier includes borate bioactive glass, graphene oxide and propylene glycol, which can increase the dissolution rate of the water-soluble chitosan and increase the ability of the healing agent to resist degradation by pancreatic juice. DETAILED DESCRIPTION
[0031] Preparation Example Preparation Example 1 of Oxidized Sodium Alginate Containing Dialdehyde Group Preparation Example 1: Weigh 2 g of sodium alginate powder, add 98 g of water, stir and dissolve to obtain a sodium alginate aqueous solution, adjust the pH value to 5.5 with a 1 mol / l hydrochloric acid aqueous solution, add 0.27 g of oxidant KIO4, seal, wrap with black paper to avoid light, stir and oxidize at 4°C for 36 hours, then put the reaction solution into a dialysis bag with a molecular weight cutoff of 8000 Daltons, dialyze in a 5L beaker containing 2L of distilled water at 4°C for 30 hours in a dark environment, wherein the distilled water is replaced every 6 hours. After the dialysis is completed, the liquid in the dialysis bag is placed in a freeze dryer and freeze-dried for 20 hours to obtain 1.78 g of pale yellow powder of oxidized sodium alginate containing dialdehyde groups, wherein the dialdehyde group percentage is 11.2% (the dialdehyde group percentage refers to the percentage of sugar units containing dialdehyde groups in the polysaccharide molecule to the total sugar units in the polysaccharide molecule).
[0032] Preparation Example 2 of Oxidized Carboxymethyl Cellulose Containing Dialdehyde Groups Preparation Example 2: Weigh 2.2g of carboxymethyl cellulose powder, mix with 97.8g of water, stir and dissolve to obtain a carboxymethyl cellulose aqueous solution; adjust the pH value of the carboxymethyl cellulose aqueous solution to 5 with a mass percentage of 5% acetic acid solution, add 0.25g of oxidant NaIO4, seal, wrap with black paper to avoid light, and stir the oxidation reaction at room temperature for 30h. After the reaction is completed, add 4 times the volume of 95% ethanol aqueous solution with stirring, precipitate, filter the precipitate, wash and desalt with 95% ethanol aqueous solution 6 times, dehydrate with anhydrous ethanol, and vacuum dry to obtain 1.95g of light yellow powder of oxidized carboxymethyl cellulose containing dialdehyde groups, and the dialdehyde percentage is 10.5% (the dialdehyde percentage refers to the percentage of sugar units containing dialdehyde groups in the polysaccharide molecule to the total sugar units in the polysaccharide molecule). Example
[0033] Embodiment 1: A method for preparing a wound hemostatic and wound healing agent, comprising the following steps: (1) Preparation of materials before surgery: Weigh the required dialdehyde-containing oxidized polysaccharide and water-soluble chitosan and set aside; (2) Dissolving the oxidized polysaccharide containing dialdehyde groups: 1 g of the oxidized polysaccharide containing dialdehyde groups was mixed with a solvent, the temperature was raised to 40° C., and then stirred at a speed of 200 r / min until completely dissolved, and filtered through a microporous filter membrane with a pore size of 0.22 μm to obtain an aqueous solution of the oxidized polysaccharide containing dialdehyde groups with a concentration of 5% by mass, wherein the solvent was sterile physiological saline, and the oxidized polysaccharide containing dialdehyde groups was the oxidized sodium alginate containing dialdehyde groups prepared in Preparation Example 1 (the dialdehyde content was 11.2%); (3) Dissolution of water-soluble chitosan: 1 g of water-soluble chitosan was mixed with a solvent, heated to 50° C., treated with a plasma discharge at a power of 70 W for 1.5 min, stirred at a speed of 200 r / min until completely dissolved, and filtered with a microporous filter membrane with a pore size of 0.22 μm to obtain a 2% water-soluble chitosan aqueous solution, wherein the solvent was sterile physiological saline, and the water-soluble chitosan was hydroxypropyl chitosan with a molecular weight of 200 KDa; (4) Mixing to form gel: Take a dialdehyde-containing oxidized polysaccharide aqueous solution and a water-soluble chitosan aqueous solution in a mass ratio of 0.78:1, add them into a double syringe respectively, and push them. The two aqueous solutions mix during the pushing process and reach the wound surface to form a gel-like wound hemostatic and wound healing agent.
[0034] Embodiment 2: A method for preparing a wound hemostatic and wound healing agent, (1) Preparation of materials before surgery: Weigh the required dialdehyde-containing oxidized polysaccharide and water-soluble chitosan and set aside; (2) Dissolution of dialdehyde-containing oxidized polysaccharide: Mix 1 g of dialdehyde-containing oxidized polysaccharide with a solvent, raise the temperature to 37°C, and then stir at 150 r / min until completely dissolved. Filter with a microporous filter membrane with a pore size of 0.22 μm to obtain a dialdehyde-containing oxidized polysaccharide aqueous solution with a concentration of 0.5% by mass. The solvent is sterile saline. The dialdehyde-containing oxidized polysaccharide is the dialdehyde-containing oxidized sodium alginate (dialdehyde content of 10.5%) prepared in Preparation Example 2.
[0035] (3) Dissolution of water-soluble chitosan: 1 g of water-soluble chitosan was mixed with a solvent, heated to 37° C., treated with a plasma discharge at 65 W for 2 min, stirred at 200 r / min until completely dissolved, and filtered with a microporous filter membrane with a pore size of 0.22 μm to obtain a 2% water-soluble chitosan aqueous solution, wherein the solvent was sterile saline, and the water-soluble chitosan was hydroxypropyl chitosan with a molecular weight of 200 KDa; (4) Mixing to form gel: Take a 1:1 mass ratio of an aqueous solution of a dialdehyde-containing oxidized polysaccharide and a water-soluble chitosan aqueous solution, add them into a double syringe respectively, and push them. The two aqueous solutions mix during the pushing process and reach the wound surface to form a gel-like wound hemostatic and wound healing agent.
[0036] Example 3: A method for preparing a wound hemostatic and wound healing agent, which differs from Example 1 in that in step (3), the water-soluble chitosan is hydroxypropyl chitosan with a molecular weight of 100 KDa, and in step (4), the mass ratio of the water-soluble chitosan solution to the aldehyde-containing oxidized polysaccharide solution is 1:1.5.
[0037] Example 4: A method for preparing a wound hemostatic and wound healing agent, which is different from Example 1 in that: (1) Preparation of materials before surgery: Weigh the required dialdehyde-containing oxidized polysaccharide and water-soluble chitosan and set aside; (2) Dissolving the oxidized polysaccharide containing dialdehyde groups: 1 g of the oxidized polysaccharide containing dialdehyde groups was mixed with a solvent, the temperature was raised to 40° C., metal ions were added, and then stirred at a speed of 200 r / min until completely dissolved, and filtered with a microporous filter membrane with a pore size of 0.22 μm to obtain an aqueous solution of the oxidized polysaccharide containing dialdehyde groups with a concentration of 5% by mass, the solvent was sterile physiological saline, the oxidized polysaccharide containing dialdehyde groups was the oxidized sodium alginate containing dialdehyde groups prepared in Preparation Example 1 (the dialdehyde content was 11.2%), the mass ratio of the oxidized sodium alginate containing dialdehyde groups to the metal ions was 1:0.03, and the metal ions were calcium chloride; (3) Dissolution of water-soluble chitosan: 1 g of water-soluble chitosan was mixed with a solvent, heated to 50° C., treated with a plasma discharge at a power of 70 W for 1.5 min, stirred at a speed of 200 r / min until completely dissolved, and filtered with a microporous filter membrane with a pore size of 0.22 μm to obtain a 2% water-soluble chitosan aqueous solution, wherein the solvent was sterile physiological saline, and the water-soluble chitosan was hydroxypropyl chitosan with a molecular weight of 100 KDa; (4) Mixing to form a gel: Take a dialdehyde-containing oxidized polysaccharide aqueous solution and a water-soluble chitosan aqueous solution in a mass ratio of 1.5:1, add them into a double syringe respectively, and push them. The two aqueous solutions mix during the pushing process and reach the wound surface to form a gel-like wound hemostatic and wound healing agent.
[0038] Example 5: A method for preparing a wound hemostatic and wound healing agent, which differs from Example 4 in that the aldehyde-containing oxidized polysaccharide is pretreated as follows: the aldehyde-containing oxidized polysaccharide is added to distilled water to make a solution with a concentration of 5wt%, the temperature is raised to 50°C, supercritical carbon dioxide is continuously introduced into the solution at a pressure of 25MPa for 2h, and then immediately freeze-dried at -60°C for 24h.
[0039] Example 6: A method for preparing a wound hemostatic and healing agent, which differs from Example 5 in that, before the prepared aldehyde-containing oxidized polysaccharide is mixed and dissolved with a solvent, the outer wall of a glass container storing the aldehyde-containing oxidized polysaccharide is repeatedly rubbed with a brush for 10 minutes to generate static electricity on the outer wall of the storage glass container; the storage glass container with static electricity on the outer wall is placed on a wooden table, and then the solvent is injected.
[0040] Embodiment 7: A method for preparing a wound hemostatic and wound healing agent, which differs from Embodiment 6 in that step (3) is specifically as follows: 1 g of water-soluble chitosan is mixed with a solvent, the mixture is heated to 50°C, and subjected to a plasma discharge treatment at a power of 70 W for 1.5 min. A cosolvent is added, and the mixture is stirred at a speed of 150 r / min until completely dissolved. The mixture is filtered through a microporous filter membrane with a pore size of 0.22 μm to obtain a water-soluble chitosan aqueous solution with a concentration of 5%. The solvent is sterile saline, the water-soluble chitosan is hydroxypropyl chitosan with a molecular weight of 1 million, the mass ratio of the cosolvent to the water-soluble chitosan is 0.1:1, and the cosolvent comprises polyethylene glycol-poly-L-lysine, sodium carbonate and polyoxyethylene fatty acid ester in a mass ratio of 1:0.5:1.
[0041] Embodiment 8: A method for preparing a wound hemostatic and wound healing agent, which differs from Embodiment 6 in that step (3) is specifically as follows: 1 g of water-soluble chitosan is mixed with a solvent, the mixture is heated to 50°C, and subjected to a plasma discharge treatment at a power of 70 W for 1.5 min. A cosolvent is added, and the mixture is stirred at a speed of 150 r / min until completely dissolved. The mixture is filtered through a microporous filter membrane with a pore size of 0.22 μm to obtain a water-soluble chitosan aqueous solution with a concentration of 5%. The solvent is sterile saline, the water-soluble chitosan is hydroxypropyl chitosan with a molecular weight of 1 million, the mass ratio of the cosolvent to the water-soluble chitosan is 0.3:1, and the cosolvent comprises polyethylene glycol-poly L-lysine, sodium carbonate and polyoxyethylene fatty acid ester in a mass ratio of 1:1:2.
[0042] Example 9: A method for preparing a wound hemostatic and wound healing agent, which differs from Example 8 in that the co-solvent comprises polyethylene glycol-poly-L-lysine and polyoxyethylene fatty acid ester in a mass ratio of 1:2.
[0043] Example 10: A method for preparing a wound hemostatic and wound healing agent, which is different from Example 8 in that the co-solvent comprises sodium carbonate and polyoxyethylene fatty acid ester in a mass ratio of 1:2.
[0044] Example 11: A method for preparing a wound hemostatic and wound healing agent, which is different from Example 8 in that the co-solvent comprises polyethylene glycol-poly-L-lysine and calcium carbonate in a mass ratio of 1:1.
[0045] Example 12: A method for preparing a wound hemostatic and wound healing agent, which is different from Example 8 in that: Step (3) is specifically as follows: 1 g of water-soluble chitosan is mixed with a solvent, the temperature is raised to 50° C., a plasma discharge treatment is performed at a power of 70 W for 1.5 min, a cosolvent and an improver are added, the mixture is stirred at a speed of 150 r / min until completely dissolved, and filtered with a microporous filter membrane with a pore size of 0.22 μm to obtain a water-soluble chitosan aqueous solution with a concentration of 5%, wherein the solvent is sterile saline, the water-soluble chitosan is hydroxypropyl chitosan with a molecular weight of 1 million, the mass ratio of the cosolvent to the water-soluble chitosan is 0.3:1, the cosolvent includes polyethylene glycol-poly L-lysine, sodium carbonate and polyoxyethylene fatty acid ester in a mass ratio of 1:1:2, the mass ratio of the improver to the water-soluble chitosan is 1:0.3, and the improver includes borate bioactive glass, graphene oxide and propylene glycol in a mass ratio of 1:3:0.3.
[0046] Example 13: A method for preparing a wound hemostatic and wound healing agent, which is different from Example 8 in that: Step (3) is specifically as follows: 1 g of water-soluble chitosan is mixed with a solvent, the temperature is raised to 50° C., a plasma discharge treatment is performed at a power of 70 W for 1.5 min, a cosolvent and an improver are added, the mixture is stirred at a speed of 150 r / min until completely dissolved, and filtered with a microporous filter membrane with a pore size of 0.22 μm to obtain a water-soluble chitosan aqueous solution with a concentration of 5%, wherein the solvent is sterile saline, the water-soluble chitosan is hydroxypropyl chitosan with a molecular weight of 120,000, the mass ratio of the cosolvent to the water-soluble chitosan is 0.3:1, the cosolvent includes polyethylene glycol-poly L-lysine, sodium carbonate and polyoxyethylene fatty acid ester in a mass ratio of 1:1:2, the mass ratio of the improver to the water-soluble chitosan is 1:0.1, and the improver includes borate bioactive glass, graphene oxide and propylene glycol in a mass ratio of 1:2:0.2.
[0047] Example 14: A method for preparing a wound hemostatic and wound healing agent, which differs from Example 13 in that the improver comprises borate bioactive glass and propylene glycol in a mass ratio of 1:0.3.
[0048] Example 15: A method for preparing a wound hemostatic and healing agent, which differs from Example 13 in that the improver comprises graphene oxide and propylene glycol in a mass ratio of 3:0.3.
[0049] Example 16: A method for preparing a wound hemostatic and wound healing agent, which differs from Example 13 in that the water-soluble chitosan is subjected to the following pretreatment: the water-soluble chitosan is added to distilled water to prepare a solution with a concentration of 5wt%, the temperature is raised to 50°C, supercritical carbon dioxide is continuously introduced into the solution at a pressure of 25MPa for 2h, and then immediately freeze-dried at -60°C for 24h.
[0050] Example 17: A method for preparing a wound hemostatic and wound healing agent, which differs from Example 16 in that, before the prepared water-soluble chitosan is mixed with the solvent, the outer wall of a water-soluble chitosan storage glass container is repeatedly brushed with a brush for 10 minutes to generate static electricity on the outer wall of the storage glass container, the storage glass container with static electricity on the outer wall is placed on a wooden table, and then the solvent is injected into the storage glass container.
[0051] Comparative Example Comparative Example 1: A method for preparing a wound hemostatic and wound healing agent, which differs from Example 1 in that step (3) specifically comprises: mixing 1 g of water-soluble chitosan with a solvent, heating to 50°C, stirring at a speed of 200 r / min until completely dissolved, filtering with a microporous filter membrane with a pore size of 0.22 μm to obtain a water-soluble chitosan aqueous solution with a mass percentage concentration of 2%, the solvent being sterile saline, and the water-soluble chitosan being hydroxypropyl chitosan with a molecular weight of 200 KDa.
[0052] Comparative Example 2: A method for preparing a wound hemostatic and wound healing agent, which differs from Example 1 in that step (3) is specifically as follows: 1 g of water-soluble chitosan is mixed with 50 ml of solvent, the temperature is raised to 50°C, and a plasma discharge treatment is performed at a power of 70 W for 5 min, and then stirred at a speed of 200 r / min until completely dissolved, and filtered through a microporous filter membrane with a pore size of 0.22 μm to obtain a water-soluble chitosan aqueous solution with a mass percentage concentration of 2%, the solvent is sterile saline, and the water-soluble chitosan is hydroxypropyl chitosan with a molecular weight of 200 KDa.
[0053] Comparative Example 3: A method for preparing a wound hemostatic and wound healing agent, which differs from Example 1 in that step (2) is specifically as follows: 1 g of water-soluble chitosan is mixed with 50 ml of solvent, the temperature is raised to 50°C, and a plasma discharge treatment is performed at a power of 50 W for 1.5 min, and then stirred at a speed of 200 r / min until completely dissolved, and filtered through a microporous filter membrane with a pore size of 0.22 μm to obtain a water-soluble chitosan aqueous solution with a mass percentage concentration of 2%, the solvent is sterile saline, and the water-soluble chitosan is hydroxypropyl chitosan with a molecular weight of 200 KDa.
[0054] Comparative Example 4: A method for preparing a wound hemostatic and wound healing agent, which differs from Example 1 in that step (3) is specifically as follows: 1 g of water-soluble chitosan is mixed with 50 ml of solvent, the mixture is heated to 30°C, stirred at a speed of 150 r / min until completely dissolved, and filtered through a microporous filter membrane with a pore size of 0.22 μm to obtain a 2% water-soluble chitosan aqueous solution, wherein the solvent is sterile saline, and the water-soluble chitosan is hydroxypropyl chitosan with a molecular weight of 200 KDa.
[0055] Comparative Example 5: A method for preparing a wound hemostatic and wound healing agent. Compared with Example 1, the mass ratio of the water-soluble chitosan aqueous solution to the aldehyde-containing oxidized polysaccharide aqueous solution is 1:1.5.
[0056] Comparative Example 6: A method for preparing a wound hemostatic and wound healing agent, comprising the steps of mixing 1 g of oxidized sodium alginate containing a dialdehyde group with 50 ml of sterile saline solution, dissolving the mixture under stirring, filtering the resulting solution with a microporous filter membrane having a pore size of 0.22 μm, and obtaining a 2% by weight aqueous solution of oxidized polysaccharides containing dialdehyde groups; weighing 1 g of water-soluble chitosan hydroxypropyl chitosan, adding 50 ml of sterile saline solution, dissolving the mixture under stirring, and filtering the resulting solution with a microporous filter membrane having a pore size of 0.22 μm, and obtaining a 2% by weight aqueous solution of hydroxypropyl chitosan; taking 40 ml of the oxidized polysaccharide containing a dialdehyde group and 50 ml of the aqueous solution of hydroxypropyl chitosan, respectively, and putting them in a double syringe, and pushing them out together when in use, so that the two aqueous solutions mix during the pushing process and reach the wound surface.
[0057] Performance testing Wound hemostatic and wound healing agents were prepared according to the methods in the examples and comparative examples, and the time for the dialdehyde-containing oxidized polysaccharide and the water-soluble chitosan to be mixed with sterile physiological saline until they were completely dissolved was recorded. After the dialdehyde-containing oxidized polysaccharide aqueous solution and the water-soluble chitosan solution were mixed, the gelation time from mixing to solidification to form a gel was recorded. Three groups were tested for each example and comparative example, and the test results were averaged. The results were recorded in Table 1.
[0058] Table 1 It can be seen from the data in Table 1 that the water-soluble chitosan with a molecular weight of 20 KDa after plasma treatment in Example 1 and Example 2 is used. Compared with the water-soluble chitosan without plasma treatment in Comparative Example 1, the plasma treatment accelerates the dissolution rate of the water-soluble chitosan and shortens the dissolution time. In Comparative Example 4, the dissolution temperature of the water-soluble chitosan is reduced, and the dissolution rate of the water-soluble chitosan is slowed down, indicating that the dissolution rate of the water-soluble chitosan is also increased when it is stirred and dissolved at a certain temperature; in Comparative Examples 2 and 3, the plasma treatment time is extended and the plasma treatment power is reduced respectively, and it can be seen that the dissolution time of the water-soluble chitosan in Comparative Examples 2 and 3 is increased. In Comparative Example 5, a water-soluble chitosan with a molecular weight of 200 KDa is used, and a water-soluble chitosan water-soluble and aldehyde-containing oxidized polysaccharide aqueous solution with a mass ratio of 1:1.5 is used. Compared with Example 1, the gelation rate of the two is reduced.
[0059] In Example 3, water-soluble chitosan with a molecular weight of 100 KDa is used, and the mass ratio of the water-soluble chitosan aqueous solution to the aldehyde-containing oxidized polysaccharide aqueous solution is 1:1.5. Compared with Example 1, the dissolution rate of the water-soluble chitosan is accelerated, and the gelation time is shortened.
[0060] Compared with Example 3, Example 4 uses water-soluble chitosan with a molecular weight of 100 KDa, and adds metal ions on the basis of a mass ratio of the water-soluble chitosan aqueous solution to the aldehyde-containing oxidized polysaccharide aqueous solution of 1:1.5. Table 1 shows that the dissolution rate of the aldehyde-containing oxidized polysaccharide is accelerated and the dissolution time is shortened.
[0061] Compared with Example 4, before the aldehyde-containing oxidized polysaccharide is used, supercritical carbon dioxide is introduced and freeze-dried to form a sponge, which further increases the dissolution rate.
[0062] Compared with Example 5, Example 6 also generates static electricity by friction on the outer wall of the glass container for storing the oxidized polysaccharide containing aldehyde groups, thereby increasing the contact area between the oxidized polysaccharide containing aldehyde groups and the solvent and accelerating the dissolution.
[0063] In Example 7 and Example 8, on the basis of improving the dissolution rate of the oxidized polysaccharide containing aldehyde groups, a cosolvent is added before the water-soluble chitosan is dissolved, thereby improving the dissolution rate of the water-soluble chitosan, shortening the dissolution time, and accelerating the gelation rate.
[0064] In Example 9, compared with Example 8, no sodium carbonate was added to the cosolvent, and the dissolution time of the water-soluble chitosan was increased, and the gelation time was also prolonged, indicating that the addition of sodium carbonate can not only accelerate the dissolution of the water-soluble chitosan, but also enhance the reaction between the water-soluble chitosan and the aldehyde-containing oxidized polysaccharide, thereby accelerating the gelation.
[0065] Compared with Example 8, polyethylene glycol-poly-L-lysine was not added in Example 10, and polyoxyethylene fatty acid ester was not added in Example 11. The dissolution time of the water-soluble chitosan in Examples 10 and 11 was increased, and the gelation time in Example 10 was also prolonged.
[0066] Compared with Example 8, in Example 12 and Example 13, an improver is added before the water-soluble chitosan is dissolved, and the improver containing ingredients such as graphene oxide is added when the water-soluble chitosan is dissolved. Table 1 shows that the dissolution rate of the water-soluble chitosan in Example 12 and Example 13 is increased, and the gelation time is shortened.
[0067] In Example 14, compared with Example 13, no graphene oxide is added to the improver. As shown in Table 1, the gelation rates of the water-soluble chitosan and the oxidized polysaccharide containing a dialdehyde group are further improved.
[0068] Compared with Example 13, in Example 15, no borate bioactive glass was added to the improver. The dissolution rate of the water-soluble chitosan in Example 15 was slowed down, and the gelation time was increased, indicating that the borate bioactive glass can increase the dissolution rate of the water-soluble chitosan and improve the gelation reaction rate of the water-soluble chitosan and the oxidized polysaccharide containing dialdehyde groups.
[0069] In Example 16, compared with Example 13, water-soluble chitosan is foamed with supercritical carbon dioxide and then freeze-dried to obtain water-soluble chitosan with a sponge structure. When dissolved again, the contact area with the solvent can be increased to improve the dissolution rate.
[0070] Compared with Example 16, Example 17 can increase solubility and reduce dissolution time by injecting solvent after static electricity is generated on the outer wall of the storage glass container.
[0071] Comparative Example 6 is a hemostatic and wound healing agent containing water-soluble chitosan and oxidized polysaccharides containing dialdehyde groups in the prior art. The water-soluble chitosan and the oxidized polysaccharides containing dialdehyde groups are stirred and dissolved separately at room temperature. The dissolution time is long and the gelation speed needs to be improved.
[0072] 2. Hemostasis and wound healing effects of wound healing agents (1) Hemostasis time: 40 Wistar rats, half male and half female, weighing 250-300 g, were randomly divided into two groups: the first group (administered with the wound healing agent prepared in Example 1), the second group (administered with the wound healing agent prepared in Example 3), the third group (administered with the wound healing agent prepared in Example 10), and the fourth group (administered with the wound healing agent prepared in Example 13), with 10 rats in each group. All rats were anesthetized by intraperitoneal injection of 2% sodium pentobarbital aqueous solution at a dose of 30 mg / kg body weight, and the rats were fixed on a surgical stand with their abdomens facing upwards. The inner sides of the two hind legs of the rats were depilated with a razor, and the depilated skin was disinfected with a cotton ball of Sanisol. After disinfection, incisions of about 30 mm long and 3 mm deep were made at the depilated parts of the inner sides of the two hind legs of the rats with a scalpel. Blood flowed out, and the oxidized polysaccharide aqueous solution containing dialdehyde groups and the water-soluble chitosan aqueous solution were placed in a double syringe respectively. After 0.5 ml was pushed out, a gel was formed on the wound surface. Ordinary sterilized gauze was used to absorb the blood exuding from the wound surface every 20 seconds, and the hemostatic effect was observed. The complete hemostasis time was recorded respectively, and the average of 10 rats was calculated. The test results were recorded in Table 2.
[0073] (2) Wound healing rate: 50 male rats weighing 250-300 g were selected and randomly divided into 5 groups, with 10 rats in each group: the first group (administered with the wound healing agent prepared in Example 1), the second group (administered with the wound healing agent prepared in Example 3), the third group (administered with the wound healing agent prepared in Example 9), the fourth group (administered with the wound healing agent prepared in Example 14) and the fifth group (administered with the wound healing agent prepared in Example 15). All rats were anesthetized by intraperitoneal injection of 2% sodium pentobarbital aqueous solution at a weight percentage concentration of 30 mg / kg. An incision of about 3 cm was made in the middle of the rat abdomen to open the abdominal cavity. The left lobe of the liver was freed under aseptic conditions. A 5 mm × 5 mm × 2 mm liver tissue block was clamped in the middle and lower part of the dry area with surgical tissue forceps to cause liver tissue defect. The bleeding time was counted for 5 seconds after the tissue was cut, and blood was sucked with medical cotton gauze. An aqueous solution of oxidized polysaccharides containing dialdehyde groups and a water-soluble chitosan aqueous solution were immediately injected into the wound surface through a double syringe to seal the liver defect wound surface. The injection volume was 0.3 ml. The wound surface was observed for 2 minutes. The surgical rats were closed and raised normally. The experimental rats were killed 2 weeks after the operation. The healing of the liver tissue defect wound surface was examined by laparotomy. The area reduction rate of the wound surface was counted, i.e. the healing rate. The test results are recorded in Table 2.
[0074] Table 2 project Hemostasis time / s Healing rate / % Example 1 32 92.6 Example 3 32 92.4 Example 4 30 92.8 Example 8 20 92.8 Example 13 19 95.7 Embodiment 14 29 92.4 It can be seen from the data in Table 2 that the wound healing agents prepared in Examples 1, 3, 4, 8, 13 and 14 have good adhesion to the wound surface, are not easily dispersed by blood, have fast hemostasis speed, and have a smooth wound surface.
[0075] 3. Prevent pancreatic juice degradation Rats weighing 250-300g, half male and half female, were selected and randomly divided into 3 groups, 10 rats in each group: the first group (administered with the wound healing agent prepared in Example 1), the second group (administered with the wound healing agent prepared in Example 13), and the third group (administered with the wound healing agent prepared in Example 14). All rats were anesthetized by intraperitoneal injection of a 2% sodium pentobarbital aqueous solution by weight percentage, the injection dose was 30mg / kg, an incision of about 3cm long was made in the middle of the abdomen of the rat, the abdominal cavity was opened, and an incision of 10mm long was made on the pancreas. After the pancreatic juice flowed out for 5 seconds, the pancreatic juice was absorbed with medical cotton cloth, and the aqueous solution of oxidized polysaccharide containing dialdehyde group and the water-soluble chitosan solution were immediately injected into the damaged part of the pancreas through a double syringe, the injection volume was 0.3ml, the wound surface was observed for 2 minutes, the abdomen of the operated rats was closed, and they were fed normally. The experimental rats were killed 2 weeks after the operation, and the wound surface and surrounding tissue conditions were examined by opening the abdomen, and the observation results were recorded in Table 3.
[0076] Table 3 project Wound healing rate / % Condition of tissues around the wound Example 1 90.2 No adhesion, slight corrosion of tissue around the wound Example 13 95.6 Smooth surface, no adhesion, fresh tissue, no corrosion Embodiment 14 90.5 No adhesion, slight corrosion of tissue around the wound Table 3 shows that the wound healing agents prepared in Example 1, Example 13 and Example 14 can firmly adhere to the pancreatic wound surface when used on the pancreatic wound surface, making it difficult for pancreatic juice to leak, and are not easily degraded by pancreatic juice and lose their adhesion, thereby preventing the pancreatic juice from corroding the surrounding tissues.
[0077] In Example 13, an improver is added to the water-soluble chitosan solution. The improver contains ingredients such as graphene oxide, which can further improve the ability of the healing agent to resist degradation by pancreatic juice, thereby better healing the wound surface around the pancreas. In Example 14, because graphene oxide is not added to the improver, the healing agent prepared thereby adheres to the wound surface of the pancreas, and the ability to resist degradation by pancreatic juice is sometimes reduced.
[0078] This specific embodiment is merely an explanation of the present application and is not a limitation of the present application. After reading this specification, those skilled in the art may make modifications to the present embodiment without any creative contribution as needed, but such modifications are protected by the patent law as long as they are within the scope of the claims of the present application.
Claims
1. A method for preparing a wound hemostatic and wound healing agent, characterized in that: The following steps are involved: Preparation of materials before surgery: weigh the required oxidized polysaccharide containing dialdehyde groups and water-soluble chitosan and set aside; Dissolving the oxidized polysaccharide containing dialdehyde groups: mixing the oxidized polysaccharide containing dialdehyde groups with a solvent, heating to 37-40° C., and then stirring until completely dissolved to obtain an aqueous solution of the oxidized polysaccharide containing dialdehyde groups with a concentration of 0.5-5% by mass; Dissolving water-soluble chitosan: Mix water-soluble chitosan with a solvent, raise the temperature to 37-50°C, treat with plasma discharge at a power of 65-70W for 1.5-2min, stir at a speed of 150-200r / min until completely dissolved, and prepare a water-soluble chitosan aqueous solution; Mixing to form gel: taking a dialdehyde-containing oxidized polysaccharide aqueous solution and a water-soluble chitosan aqueous solution in a mass ratio of 0.7-1.5:1, adding them into a double syringe respectively, and injecting them to form a gel-like wound hemostatic and wound healing agent; The oxidized polysaccharide containing dialdehyde groups is selected from the group consisting of oxidized hydroxyethyl cellulose containing dialdehyde groups, oxidized hydroxypropyl cellulose containing dialdehyde groups, oxidized carboxymethyl cellulose sodium salt or potassium salt containing dialdehyde groups, oxidized chitosan containing dialdehyde groups, oxidized hydroxyethyl chitosan containing dialdehyde groups, oxidized hydroxypropyl chitosan containing dialdehyde groups, oxidized carboxymethyl chitosan sodium salt or potassium salt containing dialdehyde groups, oxidized hydroxyethyl chitin containing dialdehyde groups, oxidized hydroxypropyl chitin containing dialdehyde groups, oxidized carboxymethyl chitin sodium salt or potassium salt containing dialdehyde groups, oxidized hyaluronic acid sodium salt or potassium salt containing dialdehyde groups, and oxidized alginate sodium salt or potassium salt containing dialdehyde groups; The water-soluble chitosan is selected from one of carboxymethyl chitosan sodium salt or potassium salt, hydroxyethyl chitosan and hydroxypropyl chitosan.
2. The method for preparing the wound hemostatic and wound healing agent according to claim 1, characterized in that: When the water-soluble chitosan is dissolved, before the plasma discharge treatment, a co-solvent is added, and the mass ratio of the water-soluble chitosan to the co-solvent is 1:0.1-0.
3.
3. The method for preparing the wound hemostatic and wound healing agent according to claim 2, characterized in that: The cosolvent comprises polyethylene glycol-poly-L-lysine, sodium carbonate and polyoxyethylene fatty acid ester in a mass ratio of 1:0.5-1:1-2.
4. The method for preparing the wound hemostatic and wound healing agent according to claim 1, characterized in that: When the water-soluble chitosan is dissolved, an improver is added, and the improver comprises borate bioactive glass, graphene oxide and propylene glycol in a mass ratio of 1:2-3:0.2-0.
3.
5. The method for preparing the wound hemostatic and wound healing agent according to claim 4, characterized in that: The mass ratio of the water-soluble chitosan to the improver is 1:0.1-0.
3.
6. The method for preparing the wound hemostatic and wound healing agent according to claim 1, characterized in that: The water-soluble chitosan is a water-soluble chitosan with a molecular weight of 50KDa-100KDa.
7. The method for preparing the wound hemostatic and wound healing agent according to claim 6, characterized in that: Metal ions are added before the aldehyde-containing oxidized polysaccharide is dissolved. The metal ions are selected from at least one of calcium chloride, zinc chloride, copper sulfate and ferric chloride. The mass ratio of the aldehyde-containing oxidized polysaccharide to the metal ions is 1:0.005-0.
03.
8. The method for preparing the wound hemostatic and wound healing agent according to claim 1, characterized in that: The water-soluble chitosan and the oxidized polysaccharide containing aldehyde groups are pretreated as follows: The water-soluble chitosan and the oxidized polysaccharide containing dialdehyde groups are added to the solvent respectively, and nitrogen or supercritical carbon dioxide is continuously filled for 10-20 minutes before freeze drying.
9. The method for preparing the wound hemostatic and wound healing agent according to claim 1, characterized in that: Before mixing and dissolving the water-soluble chitosan or aldehyde-containing oxidized polysaccharide with the solvent, rub the outer wall of the storage glass container of the water-soluble chitosan or aldehyde-containing oxidized polysaccharide repeatedly with a brush for 5-10 minutes to generate static electricity on the outer wall of the storage glass container, and then inject the solvent.
10. A wound hemostasis and wound healing agent, characterized in that: The wound hemostatic and wound healing agent is prepared by the preparation method of any one of claims 1 to 9.
Citation Information
Cited By
Pre-filled gel system for hemostasis of bone wound under endoscope and preparation method of pre-filled gel system
CN121534216A
